Siemens Healthineers AG (0PMJ.L)
EUR 44.91
(-0.18%)
EUR 44.91
(-0.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 5.59 Billion EUR | 0.41% |
| 2023 | 5.57 Billion EUR | 6.96% |
| 2022 | 5.21 Billion EUR | 18.61% |
| 2021 | 4.39 Billion EUR | 20.87% |
| 2020 | 3.63 Billion EUR | 3.89% |
| 2019 | 3.5 Billion EUR | -0.2% |
| 2018 | 3.5 Billion EUR | 1.01% |
| 2017 | 3.47 Billion EUR | 3.64% |
| 2016 | 3.35 Billion EUR | 7.86% |
| 2015 | 3.1 Billion EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.36 Billion EUR | -0.66% |
| 2024 Q1 | 1.36 Billion EUR | -4.53% |
| 2024 Q3 | 1.4 Billion EUR | 3.09% |
| 2023 FY | 5.57 Billion EUR | 6.96% |
| 2023 Q3 | 1.36 Billion EUR | -4.67% |
| 2023 Q4 | 1.43 Billion EUR | 4.82% |
| 2023 Q1 | 1.33 Billion EUR | -7.27% |
| 2023 Q2 | 1.43 Billion EUR | 7.17% |
| 2022 Q1 | 1.21 Billion EUR | -9.92% |
| 2022 Q4 | 1.44 Billion EUR | 13.43% |
| 2022 Q3 | 1.27 Billion EUR | -0.39% |
| 2022 Q2 | 1.27 Billion EUR | 5.01% |
| 2022 FY | 5.21 Billion EUR | 18.61% |
| 2021 Q1 | 883 Million EUR | -3.29% |
| 2021 FY | 4.39 Billion EUR | 20.87% |
| 2021 Q4 | 1.35 Billion EUR | 8.17% |
| 2021 Q3 | 1.24 Billion EUR | 37.1% |
| 2021 Q2 | 911 Million EUR | 3.17% |
| 2020 Q1 | 959 Million EUR | 4.92% |
| 2020 FY | 3.63 Billion EUR | 3.89% |
| 2020 Q2 | 904 Million EUR | -5.74% |
| 2020 Q4 | 913 Million EUR | 5.79% |
| 2020 Q3 | 863 Million EUR | -4.54% |
| 2019 Q4 | 914 Million EUR | 3.16% |
| 2019 Q3 | 886 Million EUR | 3.02% |
| 2019 Q2 | 860 Million EUR | 2.5% |
| 2019 Q1 | 839 Million EUR | -9.88% |
| 2019 FY | 3.5 Billion EUR | -0.2% |
| 2018 Q4 | 931 Million EUR | 14.23% |
| 2018 FY | 3.5 Billion EUR | 1.01% |
| 2018 Q3 | 815 Million EUR | -11.61% |
| 2018 Q2 | 922 Million EUR | 9.89% |
| 2018 Q1 | 839 Million EUR | -8.0% |
| 2017 Q1 | 833 Million EUR | 0.0% |
| 2017 FY | 3.47 Billion EUR | 3.64% |
| 2017 Q3 | 841 Million EUR | -5.08% |
| 2017 Q2 | 886 Million EUR | 6.36% |
| 2017 Q4 | 912 Million EUR | 8.44% |
| 2016 FY | 3.35 Billion EUR | 7.86% |
| 2015 FY | 3.1 Billion EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cegedim SA | 235.64 Million EUR | -2275.991% |
| Guerbet SA | 550.79 Million EUR | -916.531% |
| Nexus AG | 44.98 Million EUR | -12346.371% |
| Bastide Le Confort Médical SA | 1.91 Million EUR | -292428.736% |
| Revenio Group Oyj | 18.8 Million EUR | -29681.915% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | -334.532% |
| Sartorius Aktiengesellschaft | 1.02 Billion EUR | -447.579% |
| LNA Santé SA | 178.1 Million EUR | -3043.598% |
| Medios AG | 23.03 Million EUR | -24206.49% |
| Equasens Société anonyme | 14.67 Million EUR | -38066.326% |
| Stratec SE | 41.95 Million EUR | -13244.615% |